ROIV
Roivant Sciences Ltd.Healthcare$28.33
▼ Bearish
Mkt Cap: $20.28B|Float: 527.2M|SI: 4.4%|DTC: 4.1
Data as of market close Apr 2, 2026
IV Rank
36
IV Pctl
44%
HV 20d
3888.0%
52W Range
$9-$30
ATR(14)
$1.05
Exp. Move
±12.4%
P/C Ratio
0.73
Earnings
May 28
GEX Positive
DEX Long
Net Put Premium
IV Moderate
Max Pain Below
Exp. Move Wide
ROIV Key Options Data
- IV Rank
- 36%
- Total GEX
- $0.00B
- Total DEX
- $1.6M
- Max Pain
- $27.00
- Expected Move
- ±12.4%
- Put/Call OI
- 0.73
- Net Premium
- $-0.4M
- Spot Price
- $28.33
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.53 | ±12.4% | $24.80 | $31.85 |
| 2026-05-15 | 43 | ±$3.67 | ±13.0% | $24.65 | $32.00 |
| 2026-08-21 | 141 | ±$3.95 | ±13.9% | $24.38 | $32.28 |
| 2026-11-20 | 232 | ±$4.60 | ±16.2% | $23.73 | $32.93 |
| 2026-12-18 | 260 | ±$4.20 | ±14.8% | $24.13 | $32.53 |
| 2027-01-15 | 288 | ±$9.20 | ±32.5% | $19.13 | $37.53 |
Explore ROIV options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.